md 780236 has been researched along with cimoxatone in 1 studies
| Studies (md 780236) | Trials (md 780236) | Recent Studies (post-2010) (md 780236) | Studies (cimoxatone) | Trials (cimoxatone) | Recent Studies (post-2010) (cimoxatone) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 26 | 3 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, MS; Dostert, P; Guffroy, C; Tipton, KF | 1 |
1 other study(ies) available for md 780236 and cimoxatone
| Article | Year |
|---|---|
Partial or total protection from long-acting monoamine oxidase inhibitors (MAOIs) by new short-acting MAOIs of type A MD780515 and type B MD780236.
Topics: Animals; Brain; Clorgyline; Dose-Response Relationship, Drug; Female; Liver; Male; Monoamine Oxidase Inhibitors; Myocardium; Oxazoles; Oxazolidinones; Rats; Rats, Inbred Strains; Selegiline; Tranylcypromine | 1983 |